LaBrosse Nicole sold HALO
February 20, 2026 · Form 4 insider transaction
LaBrosse Nicole sold 2,876 shares of Halozyme Therapeutics, Inc. at $70.98 per share, a transaction worth $204.1K. The trade was recorded as shares withheld for taxes and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Disposed (sell-side)
Shares
2,876
Price
$70.98
Total value
$204.1K
InsiderLaBrosse Nicole
RoleOfficer
SecurityCommon Stock
Transaction codeF: Shares withheld for taxes
Transaction dateFebruary 20, 2026
Filing dateFebruary 24, 2026
Shares owned after35,414
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The reported disposition of 2,876 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations.